Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China.

The entities involved

• China →

  cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China

  • The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
  • The Middle Corridor, linking Central Asia and Europe, is gaining significance in regional trade and energy routes.Mon 17:06
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
• Medtech →

  medical education facility founded in 2004 in Indianapolis, U.S

  • Alkem Laboratories built its MedTech business from the ground up and its board thanked the CFO for strategic mandates.Thu 08:21

Related events

• Johnson & Johnson highlighted growth opportunities within the MedTech sector.Sep 10
• Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.Jun 7
• AbbVie and Johnson & Johnson are top exposures in the VYM ETF, which itself holds Microsoft.Sep 5
• Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.Sep 15